New virus therapy targets bladder cancer after standard treatment fails
NCT ID NCT02143804
First seen Apr 04, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study tested a virus-based treatment called CG0070 for people with a high-grade type of bladder cancer that did not respond to standard therapy (BCG) and who chose not to have their bladder removed. The goal was to see if the treatment could control the cancer and reduce the need for surgery. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BCG Oncology
Phoenix, Arizona, 85032, United States
Conditions
Explore the condition pages connected to this study.